Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer

Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer

Thumbnail Image
Download
Name

Ooi-2009-Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer.pdf

Size

1.29 MB

Format

Adobe PDF

Checksum (MD5)

daaed71303defa49016a15e0f504d9bd

Author(s)
Ooi, Chia Huey
•
Ivanova, Tatiana
•
Wu, Jeanie
•
Lee, Minghui
•
Tan, Iain Beehuat
•
Tao, Jiong
•
Ward, Lindsay
•
Koo, Jun Hao
•
Gopalakrishnan, Veena
•
Zhu, Yansong
more
Date Issued
October 2009
Journal
PLoS Genetics
Publisher
Public Library of Science
Citation
Ooi, Chia Huey et al. “Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer.” Ed. Jason G. Mezey. PLoS Genetics 5.10 (2009) : e1000676.
Version
Final published version
Abstract
Many solid cancers are known to exhibit a high degree of heterogeneity in their deregulation of different oncogenic pathways. We sought to identify major oncogenic pathways in gastric cancer (GC) with significant relationships to patient survival. Using gene expression signatures, we devised an in silico strategy to map patterns of oncogenic pathway activation in 301 primary gastric cancers, the second highest cause of global cancer mortality. We identified three oncogenic pathways (proliferation/stem cell, NF-κB, and Wnt/β-catenin) deregulated in the majority (>70%) of gastric cancers. We functionally validated these pathway predictions in a panel of gastric cancer cell lines. Patient stratification by oncogenic pathway combinations showed reproducible and significant survival differences in multiple cohorts, suggesting that pathway interactions may play an important role in influencing disease behavior. Individual GCs can be successfully taxonomized by oncogenic pathway activity into biologically and clinically relevant subgroups. Predicting pathway activity by expression signatures thus permits the study of multiple cancer-related pathways interacting simultaneously in primary cancers, at a scale not currently achievable by other platforms.
MIT Department
Singapore-MIT Alliance in Research and Technology (SMART)
Terms of Use
Creative Commons Attribution
http://creativecommons.org/licenses/by/2.5/
Persistent DSpace Link
http://hdl.handle.net/1721.1/64929
DOI of Published Version
https://doi.org/10.1371/journal.pgen.1000676
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.